" class="no-js "lang="en-US"> Alisa Thoren, Author at Pharmtech Focus
Tuesday, January 31, 2023

Sort by:

Date

Top Post

ProPharma Acquires UK Based Digital Lab Consulting

ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]

Remington Announces Launch of VascuChek®, A Wireless, Vascular Doppler Device

Remington Medical, a medical device manufacturing company based in the U.S., announced the launch of […]

Telix and RefleXion Expand Partnership for Prostate Cancer Treatment

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) […]

Optibrium Strengthens Global AI Drug Discovery Software Operations With Three Key Appointments

Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, today […]

Pfizer Completes Acquisition of Biohaven Pharmaceuticals

Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding […]

Liverpool Heart and Chest Hospital Selects Clinical Informatics Provider Epro as Digital Partner

Leading healthcare informatics provider Epro has been selected by the Liverpool Heart and Chest Hospital (LHCH) to […]

Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products […]

  1. MedRhythms Feasibility Study Shows Positive Topline Results in Parkinson’s Disease Read more
  2. Ionis receives FDA Fast Track designation for Olezarsen in patients with Familial Chylomicronemia Syndrome Read more
  3. Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear Read more
  4. Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors Read more
  5. Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors Read more